Skip to content

Public FDA record

Z-1745-2022: INOmax DSIR -(delivery system) delivers INOMAX (nitric oxide for inhalation) therapy gas into the inspira

Recall record Z-1745-2022 for Mallinckrodt, LLC.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1745-2022
Company in FDA record
Mallinckrodt, LLC.
FDA classification date
Sep 13, 2022
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The INOmax DSIR Delivery System, manufactured by Mallinckrodt Pharmaceuticals, is not compatible with the upgraded version of the Leoni Plus ventilator, manufactured by Lowenstein Medical. The Leoni Plus ventilator was recently upgraded in 2021 by Lowenstein Medical, with new hardware and software, and the upgraded version cannot be appropriately connected with the INOmax DSIR as instructed in the INOmax DSIR Operators Manual (OM). The INOmax DSIR OM requires the use of a one-way valve with the Leoni Plus ventilator during High Frequency Oscillatory Ventilation mode and warns that use of the device without a one-way valve may result in high Nitric Oxide (NO) delivery.

Source facts

Action
Mallinkrodt issued via email on 6/23/22 an Urgent Field Safety Notice (FA-R-0023) stating reason for recall, health risk and action to take: Upon receipt of this Field Safety Notice (FSN), INOmax DSIR operators are advised not to use an upgraded Leoni Plus ventilator with the INOmax DSIR. The INOmax DSIR Validated Ventilator List, supplied as Technical Bulletin TB-20005, will be revised to remove the Leoni Plus ventilator and distributed as soon as it is available. A response form is required for this FSN. Please complete the attached form and return as instructed.
Initiated
2022-06-23
Root cause
Under Investigation by firm
Distribution
Foreign Only: Argentina Australia Austria Beligum Canada Chile Columbia Czech Republic Denmark Ecuador Estonia Finland France Germany Great Britain Hungary Iceland Ireland Italy Latvia Mexico Netherlands Norway Poland Portugal Romania Slovakia South Africa Spain Sweden Switzerland UAE Uruguay
Recall number
Z-1745-2022
Recall status
Open, Classified
CDRH record ID
195568
FDA classified
2022-09-13
Recall event number
90723

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗